Skip to search.
 TSX Down 0.19% TSX Ventures Up 0.14%

Novavax, Inc. (NVAX)

-NasdaqGS
2.08 Up 0.02(0.97%) Sep 30, 4:00PM EDT
|After Hours : 2.09 Up 0.01 (0.48%) Sep 30, 7:59PM EDT
Prev Close:2.06
Open:2.08
Bid:2.07 x 1400
Ask:2.10 x 9600
1y Target Est:6.74
Beta:1.91213
Earnings Date:Nov 7 - Nov 11 (Est.)
Day's Range:1.98 - 2.09
52wk Range:1.16 - 9.23
Volume:16,892,216
Avg Vol (3m):16,110,400
Market Cap:563.43M
P/E (ttm):N/A
EPS (ttm):-0.99
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
NVAXUp 0.97%563.43M
MRKUp 0.81%172.58B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):29.21
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.09
Quarterly EPS Est (Sep-16) :-0.26
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback